A Study of Infliximab in Patients With Sarcoidosis
Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of infliximab
(Remicade) in patients with Chronic Sarcoidosis. Infliximab (Remicade) targets specific
proteins in the body's immune system to help control the development of inflammation to help
reduce painful disease.